Nov 17, 2015 8:30am EST AntriaBio Receives Notice of Allowance on Patent Covering Microsphere Drug Delivery Platform
Sep 16, 2015 7:30am EDT AntriaBio Announces New Product Candidate, AB301, a Weekly GLP-1 Agonist and Basal Insulin Combination, for Type 2 Diabetes
Jun 08, 2015 7:30am EDT AntriaBio Announces Promising Preclinical Results for Once-Weekly Basal Insulin AB101
May 11, 2015 8:00am EDT AntriaBio to Present New Preclinical Data at the American Diabetes Association 75th Scientific Sessions
Jan 08, 2015 7:35am EST AntriaBio Announces Appointment of Dr. Hoyoung Huh as Chairman of Scientific Advisory Board and Business Development
